221 related articles for article (PubMed ID: 15595679)
1. [Experimental study on the penetrability of trypan blue to the rat prostate].
Wang H; Chen Z; Zhu Y
Zhonghua Nan Ke Xue; 2004 Nov; 10(11):811-4. PubMed ID: 15595679
[TBL] [Abstract][Full Text] [Related]
2. [Penetrability and therapeutic effect of vancomycin to the prostates of rats with bacterial prostatitis (BP) or BPH-BP].
Wang H; Chen ZH; Zhu YY; Wang T; Wu XJ
Zhonghua Nan Ke Xue; 2006 Jun; 12(6):490-5. PubMed ID: 16833184
[TBL] [Abstract][Full Text] [Related]
3. [Penetrability of amikacin into prostate tissues in rat models of chronic bacterial prostatitis].
Wang H; Li ZC; Luo ZH; Chen ZH
Zhonghua Nan Ke Xue; 2008 Jul; 14(7):583-9. PubMed ID: 18686376
[TBL] [Abstract][Full Text] [Related]
4. Anthocyanin extracted from black soybean reduces prostate weight and promotes apoptosis in the prostatic hyperplasia-induced rat model.
Jang H; Ha US; Kim SJ; Yoon BI; Han DS; Yuk SM; Kim SW
J Agric Food Chem; 2010 Dec; 58(24):12686-91. PubMed ID: 21121678
[TBL] [Abstract][Full Text] [Related]
5. [Expression of estrogen receptor beta in benign prostatic hyperplasia complicated by chronic prostatitis].
Yang GQ; Li SW; Zheng H; Zhang WB; Hu WL; Zheng XM
Zhonghua Nan Ke Xue; 2009 Apr; 15(4):314-7. PubMed ID: 19472903
[TBL] [Abstract][Full Text] [Related]
6. [Influence of androgen on Bcl-2 mRNA expression in BPH tissue].
Wang X; Ye H; Jiang H; Xu Q; Zhu J; Hou S
Zhonghua Wai Ke Za Zhi; 2000 Mar; 38(3):198-200. PubMed ID: 11832028
[TBL] [Abstract][Full Text] [Related]
7. [Expressions of SIgA and alpha 1-AR in benign prostatic hyperplasia combined with chronic prostatitis and their implications].
Gao WJ; Wang YM; Wang CH; Yang XK; Wan L; Li WP
Zhonghua Nan Ke Xue; 2013 Apr; 19(4):315-20. PubMed ID: 23678709
[TBL] [Abstract][Full Text] [Related]
8. [Expression of Ki-67, Bcl-2,Bax and caspase-3 in benign prostatic hyperplasia combined with prostatitis and their significances].
Wang L; Yang JR; Yang LY; Liu ZT; Rao JM; Liu LF
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 33(3):222-6. PubMed ID: 18382056
[TBL] [Abstract][Full Text] [Related]
9. Effect of the phytotherapeutic agent Eviprostat on 17beta-estradiol-induced nonbacterial inflammation in the rat prostate.
Oka M; Ueda M; Oyama T; Kyotani J; Tanaka M
Prostate; 2009 Sep; 69(13):1404-10. PubMed ID: 19489033
[TBL] [Abstract][Full Text] [Related]
10. [Angiogenesis and regulatory factors in rats with BPH induced by testosterone].
Shao JC; Wang Y; Zhang SW; Luo DK; Chang DG; Wu XQ; Tang M; He ZM
Zhonghua Nan Ke Xue; 2005 Jun; 11(6):413-8. PubMed ID: 15999482
[TBL] [Abstract][Full Text] [Related]
11. Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia.
Penna G; Mondaini N; Amuchastegui S; Degli Innocenti S; Carini M; Giubilei G; Fibbi B; Colli E; Maggi M; Adorini L
Eur Urol; 2007 Feb; 51(2):524-33; discussion 533. PubMed ID: 16905241
[TBL] [Abstract][Full Text] [Related]
12. [Pathological changes of benign hyperplastic prostate after removal of innervation of cholinergic pelvic nerve: experiment with spontaneous hypertension rats].
Cai JL; Xin DQ; He Q; Tang XQ; Na YQ
Zhonghua Yi Xue Za Zhi; 2008 May; 88(18):1284-8. PubMed ID: 18844105
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia.
Liu L; Li Q; Han P; Li X; Zeng H; Zhu Y; Wei Q
Urology; 2009 Aug; 74(2):340-4. PubMed ID: 19464042
[TBL] [Abstract][Full Text] [Related]
14. [Expressions of endothelin-1 in benign prostatic hyperplasia and prostate cancer and their significance].
Zhou WQ; Sun YH; Yin HL; Zhang ZY; Ge JP; Cheng W; Ma HQ; Wei W; Zhou SG; Ma HH; Gao JP
Zhonghua Nan Ke Xue; 2007 Aug; 13(8):685-9. PubMed ID: 17918704
[TBL] [Abstract][Full Text] [Related]
15. Could inflammation be a key component in the progression of benign prostatic hyperplasia?
Kramer G; Marberger M
Curr Opin Urol; 2006 Jan; 16(1):25-9. PubMed ID: 16385197
[TBL] [Abstract][Full Text] [Related]
16. Vascular resistance in the prostate evaluated by colour Doppler ultrasonography: is benign prostatic hyperplasia a vascular disease?
Berger AP; Horninger W; Bektic J; Pelzer A; Spranger R; Bartsch G; Frauscher F
BJU Int; 2006 Sep; 98(3):587-90. PubMed ID: 16796699
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress parameters in patients with prostate cancer, benign prostatic hyperplasia and asymptomatic inflammatory prostatitis: A prospective controlled study.
Kaya E; Ozgok Y; Zor M; Eken A; Bedir S; Erdem O; Ebiloglu T; Ergin G
Adv Clin Exp Med; 2017 Oct; 26(7):1095-1099. PubMed ID: 29211357
[TBL] [Abstract][Full Text] [Related]
18. [Inflammatory changes in the obstructed prostate: the correlation between the bacteriological and histological findings].
Soler Soler JL; Martínez Torres JL; Hidalgo Domínguez Mdel R; Lardelli Claret P; Liébana Ureña J; Zuluaga Gómez A; Saharour G
Arch Esp Urol; 1999 Sep; 52(7):729-38. PubMed ID: 10540763
[TBL] [Abstract][Full Text] [Related]
19. Preventive effects of D-004, a lipid extract from Cuban royal palm (Roystonea regia) fruits, on testosterone-induced prostate hyperplasia in intact and castrated rodents.
Arruzazabala ML; Carbajal D; Más R; Molina V; Rodríguez E; González V
Drugs Exp Clin Res; 2004; 30(5-6):227-33. PubMed ID: 15700750
[TBL] [Abstract][Full Text] [Related]
20. Salient and co-morbid features in benign prostatic hyperplasia: a histopathological study of the prostate.
Shakya G; Malla S; Shakya KN
Kathmandu Univ Med J (KUMJ); 2003; 1(2):104-9. PubMed ID: 16388207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
